| Recruiting | Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in NCT06904066 | National Cancer Institute (NCI) | Phase 1 |
| Recruiting | A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid NCT07148180 | Jacqueline Garcia, MD | Phase 1 / Phase 2 |
| Recruiting | Effect of APA on Sleep Quality in Children With Cancer From 5 to 16 Years NCT06455592 | University Hospital, Clermont-Ferrand | N/A |
| Recruiting | Development of a Multi-biomarker Panel for Prognostic Stratification and Treatment Response Prediction in Acut NCT07305090 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Recruiting | A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties NCT07052916 | Memorial Sloan Kettering Cancer Center | N/A |
| Recruiting | Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial NCT06510699 | The University of Queensland | Phase 2 |
| Not Yet Recruiting | Development of an Intervention Integrating Procedures Combining Hypnosis and Virtual Reality in the Support of NCT06817759 | Ciusss de L'Est de l'Île de Montréal | N/A |
| Recruiting | Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE) NCT06469307 | Dana-Farber Cancer Institute | N/A |
| Recruiting | Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue NCT06482515 | University of Maryland, Baltimore | Phase 2 |
| Active Not Recruiting | Understanding the Implementation of Cued Exercise Using Wearable Devices and a Custom Smartphone Application F NCT06645132 | Medical College of Wisconsin | N/A |
| Completed | Enhanced Assistance During Radiotherapy for Unmet Essential Needs NCT06582849 | Washington University School of Medicine | N/A |
| Not Yet Recruiting | Clinical Evaluation of the Scopio Cell Morphology Technology NCT06574308 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Withdrawn | MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies NCT06543511 | Dana-Farber Cancer Institute | N/A |
| Completed | Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptabil NCT06168825 | Inova Health Care Services | — |
| Recruiting | IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Can NCT06119685 | Indapta Therapeutics, INC. | Phase 1 / Phase 2 |
| Active Not Recruiting | Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hemat NCT05873205 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Unknown | Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201) NCT05692713 | University of British Columbia | — |
| Recruiting | Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular T NCT05646576 | Massachusetts General Hospital | N/A |
| Recruiting | Immune Profiling for Cancer Immunotherapy Response NCT06116032 | Dartmouth-Hitchcock Medical Center | — |
| Not Yet Recruiting | Allogeneic T Cells Expressing T Cell Receptor-KDEL and the Chimeric Antigen Receptor CAT19 for the Treatment o NCT05391490 | University College, London | Phase 1 |
| Recruiting | European Rare Blood Disorders Platform (ENROL) NCT06250595 | Hospital Universitari Vall d'Hebron Research Institute | — |
| Recruiting | Early Integration of Palliative and Supportive Care in Cellular Therapy NCT05190653 | Alberta Health Services, Calgary | N/A |
| Completed | Positive Psychology Intervention In HSCT NCT05147311 | Brigham and Women's Hospital | N/A |
| Withdrawn | A Study of Fedratinib With IDH Inhibition in Advanced-Phase, IDH-Mutated Ph-Negative Myeloproliferative Neopla NCT04955938 | University of Chicago | Phase 1 |
| Withdrawn | Intervention for Caregivers of Patients Undergoing HSCT or CAR T-cell Therapy NCT04390542 | Case Comprehensive Cancer Center | N/A |
| Completed | Central Nervous System Disorders Following Hematopoietic Stem Cell Transplantation NCT04737785 | European Society for Blood and Marrow Transplantation | — |
| Unknown | Neurocognitive and Psychosocial Outcomes Among Pediatric Brain Tumor and Blood Cancer Patients NCT05709522 | Aga Khan University | — |
| Unknown | Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study NCT04372524 | University of British Columbia | — |
| Completed | A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of C NCT04419623 | Telios Pharma, Inc. | Phase 1 |
| Recruiting | Better Leukemia Diagnostics Through AI (BELUGA) NCT04466059 | Munich Leukemia Laboratory | — |
| Completed | Rehabilitation Needs of the Malaysian Haematological Cancer Survivors NCT04236063 | University of Malaya | — |
| Completed | Resiliency in Older Adults Undergoing Bone Marrow Transplant NCT04188678 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | — |
| Completed | A Proof-of-Concept Trial of a Positive Psychology Intervention for Allogeneic Stem Cell Transplant Patients NCT03654404 | Brigham and Women's Hospital | N/A |
| Completed | Predictive Markers of Response and Toxicity in Patients With a Haematological Malignancy Treated With Immunoth NCT05450367 | Assistance Publique - Hôpitaux de Paris | — |
| Recruiting | The Leukemia and Lymphoma Society (LLS) National Research Registry NCT04806295 | Blood Cancer United | — |
| Terminated | Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL NCT02361346 | Molecular Templates, Inc. | Phase 1 / Phase 2 |
| Completed | A Phase 1, Dose-escalation Study of MEDI-551 in Japanese Adult Patients With Relapsed or Refractory Advanced B NCT01957579 | AstraZeneca | Phase 1 |
| Completed | Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors NCT00962494 | Stanford University | Phase 2 |
| Completed | TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD NCT00185796 | Stanford University | Phase 2 |
| Completed | Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older NCT00185640 | Stanford University | Phase 2 |
| Completed | A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS) NCT00230321 | Peter L Greenberg | Phase 1 / Phase 2 |
| Completed | Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple Myeloma NCT00185614 | Wen-Kai Weng | Phase 2 |
| Completed | Allogeneic Transplantation From Related Haploidentical Donors NCT00185692 | Stanford University | Phase 2 |
| Completed | Stem Cell Transplant From Matched Unrelated or Partially Matched Related Donors NCT00186225 | Stanford University | N/A |